CA2790164A1 — Method of treating a disease condition susceptible to baclofen therapy
Assigned to Sun Pharma Advanced Research Co Ltd · Expires 2011-08-25 · 15y expired
What this patent protects
The present invention discloses a gastric retentive formulation (capsule or tablet) containing baclofen. Said formulation comprises an immediate and a sustained release part whereas the sustained release part is comprised in the core of the formulation and the immediate release p…
USPTO Abstract
The present invention discloses a gastric retentive formulation (capsule or tablet) containing baclofen. Said formulation comprises an immediate and a sustained release part whereas the sustained release part is comprised in the core of the formulation and the immediate release part is present in the form of a layer which is applied on said core. The formulation is suitable for once-a-day administration.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.